Comprehensive Healthcare Systems (CMHSF | CHS): CEO Interview on Healthcare SaaS and Pipeline Growth

About this episode

Chris Cosgrove discusses Comprehensive Healthcare Systems' scalable healthcare SaaS platform and its growth potential in the benefits administration market.

What makes Comprehensive Healthcare Systems (OTCQB: CMHSF | TSXV: CHS) a story investors should be watching right now?In our exclusive interview, Chris Cosgrove, President & CEO of Comprehensive Healthcare Systems, breaks down how the company is building a scalable healthcare SaaS platform designed to automate complex benefits administration for unions, self-insured employers, third-party administrators, and government clients.CHS' proprietary Novus 360 platform is built to replace fragmented legacy systems with an integrated solution for eligibility, claims processing, pension administration, compliance, and member engagement. The company is targeting a large U.S. healthcare benefits administration software market estimated at $4B to $6B annually, while already supporting more than 1 million members and processing over $1.8B in healthcare claims.In our interview, Chris discusses:• Why CHS’s position in the government-mandated Taft-Hartley market creates a potential competitive moat• How Novus 360 can automate up to 85% of claims adjudication and improve workflow efficiency• Why the company believes it can scale through both organic growth and acquisitions• Annualized…

People in this episode

Guest: Chris Cosgrove

Topics covered

• healthcare technology
• SaaS
• claims processing
• benefits administration
• market growth
• interview

Keywords

• healthcare SaaS
• claims adjudication
• organic growth
• recurring revenue
• healthcare claims
• Taft-Hartley market
• contract targets

Mentioned in this episode

Organizations: Comprehensive Healthcare Systems, Novus 360, OTCQB, TSXV

Places: U.S.

More episodes of Small Stocks, Big Money

• CEO Lavell Malloy on Brag House's (Nasdaq: TBH) Blockchain Sports Platform & Athlete Tokenization · June 9, 2026 · 6 min
• CEO James Foster on Virax Biolabs' (VRAX) Long COVID Diagnostic & US Market Entry · May 25, 2026 · 9 min
• Jeremy Schwartz CIO of WisdomTree ($WT): $165B AUM, Mega Trends & Why WT Is a Secular Growth Stock · May 20, 2026 · 9 min
• First Phosphate (FRSPF) CEO on Agnico's $94M Bet Leaves Only 2 Independents Standing · May 12, 2026 · 8 min
• Anixa Biosciences (ANIX): CEO on Breast Cancer Vaccine, Phase 2 Catalyst & Ovarian Cancer CAR-T Data · May 11, 2026 · 9 min
• CEO Brandon Robinson on Horizon Aircraft’s (HOVR) Commercial eVTOL Advantages · April 28, 2026 · 8 min